CathWorks Company Profile

13:25 EDT 19th March 2019 | BioPortfolio

CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with coronary artery disease and economic benefits for patients and payers. The company’s focus today is specifically on bringing the CathWorks FFRangio™ System to market to provide quick, precise, and objective intraprocedural FFR guidance that is practical for every case.

News Articles [13 Associated News Articles listed on BioPortfolio]

CathWorks announces completion of $30m financing

Jim Corbett, CathWorks CEO, stated, “We are delighted to have such a notable investor leading this round and for the continued full participation of our existing syndicate of The post CathWorks ann...

CathWorks closes $30mm Series C

Cardiovascular device maker CathWorks Ltd. raised $30mm in its Series C financing round led by Deerfield Management. In late 2018, CathWorks received 510(k) clearance for its FFRangio system, which ca...

Medical imaging co CathWorks raises $30m

CathWorks has developed non-invasive technology for imaging of arteries during angiography.

Funding round pulls in $30M for CathWorks

A funding round has brought in $30 million for CathWorks, which makes noninvasive technology for arterial imaging in angiogra -More- 

CathWorks’ FFRangio system exceeds pre-specified performance goals in clinical trial

CathWorks’ FFRangio system is a non-invasive FFR platform, which rapidly and precisely delivers objective multi-vessel physiologic measurements to cost-effectively optimize and confirm intrapro...

CathWorks gets FDA clearance for FFRangio technology

The FDA has granted CathWorks 510(k) clearance for its FFRangio noninvasive fractional flow reserve analysis technology.  -More- 

CathWorks Appoints Chief Financial Officer

CathWorks announced that Mike Feher has joined CathWorks as Vice President of Finance and Chief Financial Officer. His appointment coincides with US commercialization of the CathW...

CathWorks Names Paul Kapsner as Vice-President of Sales

Provides Experienced Commercial Leadership For CathWorks FFRangio™ U.S. Launch CathWorks announced that Paul Kapsner has been named as Global Vice President of Sales....

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]


CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from v...

More Information about "CathWorks" on BioPortfolio

We have published hundreds of CathWorks news stories on BioPortfolio along with dozens of CathWorks Clinical Trials and PubMed Articles about CathWorks for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CathWorks Companies in our database. You can also find out about relevant CathWorks Drugs and Medications on this site too.

Quick Search


Relevant Topic

Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...

Corporate Database Quicklinks

Searches Linking to this Company Record